9,10-dimethyl-1,2-benzanthracene has been researched along with mangostin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, W; Liu, Z; Ma, H; Wang, F; Xu, X; Zhang, X | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and mangostin
Article | Year |
---|---|
α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinogens; Dose-Response Relationship, Drug; Female; Inflammation; Mice; Mice, Inbred ICR; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction; Skin Neoplasms; TOR Serine-Threonine Kinases; Xanthones | 2017 |